Skip to content

A randomized controlled clinical study of stellate ganglion block to improve sleep and reduce delirium after major non-cardiac surgery

A randomized controlled clinical study of stellate ganglion block to improve sleep and reduce delirium after major non-cardiac surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060492
Enrollment
Unknown
Registered
2022-06-03
Start date
2022-05-23
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Delirium

Interventions

Sponsors

Shenzhen Longgang District Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients voluntarily agreed to participate in this study and signed informed consent; 2. The patient aged over 50 years, with smooth language communication and no obvious hearing and visual impairment; 3. The patient has no history of mental illness (depression, schizophrenia), dementia, substance abuse or alcoholism; 4. Elective or limited-period general anesthesia surgery is proposed, and the surgical type is limited to non-cardiac surgery major open surgery (Major surgery is defined as tertiary or tertiary surgery performed under general anesthesia and expected operation time is more than 2 hours).

Exclusion criteria

Exclusion criteria: 1. The patient also participated in other clinical studies; 2. Long-term severe sleep disorder or insomnia; 3. Preoperative epilepsy, Parkinson's disease, myasthenia gravis; 4. Craniocerebral injury or neurosurgery; Having had neck trauma or surgery; 5. Preoperative LVEF<30%, or patients with sick sinus syndrome, severe sinus bradycardia (heart rate <50 beats/min), atrioventricular block above degree II and no pacemaker implantation; 6. Severe abnormal liver function (Child-Pugh grade C); 7. Severe renal dysfunction (preoperative dialysis); 8. Patients with ASA Grade IV or expected survival <=24 hours; 9. Cases considered unsuitable for inclusion by other researchers.

Design outcomes

Secondary

MeasureTime frame
Delirium duration;Severity of delirium;

Primary

MeasureTime frame
Incidence of delirium within 7 days after surgery;Postoperative sleep quality;Changes of plasma BDNF concentration in perioperative patients;

Countries

China

Contacts

Public ContactLi Yongwang

Shenzhen Longgang District Third People's Hospital

liyongwangmed@163.com+86 18845873676

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026